title: A comparative study of conventional and long-acting formulations of propranolol in essential hypertension.
authors.forename: C F
authors.initials: CF
authors.lastname: Hudson
authors.forename: S P
authors.initials: SP
authors.lastname: Joseph
authors.forename: D M
authors.initials: DM
authors.lastname: Lawrie
authors.forename: J L
authors.initials: JL
authors.lastname: Thirkettle
authors.forename: D
authors.initials: D
authors.lastname: Allsopp
authors.forename: J
authors.initials: J
authors.lastname: McAinsh
mesh_terms: D002986:Clinical Trials as Topic; D004304:Dosage Forms; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors
chemical_list: D004304:Dosage Forms; D011433:Propranolol